Sun, Dec 21, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Carlson Capital settles with SEC for alleged short selling scheme

Monday, September 27, 2010
Opalesque Industry Update – The Securities and Exchange Commission, the US financial regulator, filed formal charges last Friday againstCarlson Capital, LP, a $5.5bn Dallas-based hedge fund run by Clint Carlson, for alleged improper participation in four public stock offerings after selling short those same stocks.

In its order, the SEC said that Carlson violated Rule 105 on at least four occasions and even introduced internal policies and procedures that lack the necessary mechanism to prevent the firm from participating in relevant offerings.

The SEC alleged that in one occasion, the violation occurred when the portfolio manager who sold short stocks and the portfolio manager who bought the offering shares were different.

Antonia Chion, Associate Director of the SEC’s Division of Enforcement commented, "Investment advisers must recognize that combined trading by different portfolio managers can still constitute a clear violation of Rule 105 when short selling takes place during a restricted period. This is true even when the portfolio managers have different investment approaches and generally make their own trading decisions."

Under SEC Rule 105 of Regulation M, short sellers are prevented from reducing proceeds received by companies and shareholders by artificially depressing the market price shortly before the company prices its public offering. Rule 105 ensures that offering prices are set by natural forces of supply and demand rather than manipulative activity by prohibiting the short sale of an equity security during a restricted period — generally five business days before a public offering — and the purchase of that same security through the offering. The rule applies regardless of the trader's intent in selling short the stock.

On March 25, 2010, the SEC announced it was conducting investigation against Carlson Capital over four alleged secondary stock offerings between late 2007 and mid-2009.

A day later, a spokesman for Carlson admitted that the SEC was investigating the fund and that the firm was cooperating with the regulator.

"Carlson Capital has been cooperating voluntarily and fully with the SEC relating to an inquiry in connection with Rule 105 and will continue to do so," a spokesman for the fund said.

Last week (September 23), Carlson agreed to settle its case with the SEC and pay $2.65m in disgorgement, penalties and pre-judgment interest, without admitting or denying the SEC’s findings.
- P. Dumlao.

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und